AVRICORE HEALTH INC (AVCR.CA) Stock News

Canada - TSX-V:AVCR - CA0545211090 - Common Stock

0.05 CAD

0 (0%)

Last: 11/6/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AVCR.CA Latest News, Press Relases and Analysis

All

Press Releases

5 months ago - By: Avricore Health Inc.

Avricore Grants Options

5 months ago - By: Avricore Health Inc.

Avricore Appoints Rodger Seccombe as CEO

5 months ago - By: Avricore Health Inc.

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report

6 months ago - By: Avricore Health Inc.

AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track

9 months ago - By: Avricore Health Inc.

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

a year ago - By: Avricore Health Inc.

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

a year ago - By: Avricore Health Inc.

Avricore Grants Options

a year ago - By: Avricore Health Inc.

AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY

2 years ago - By: Avricore Health Inc.

Avricore Health Corporate Update – Company Demonstrates Strong Growth

a year ago - By: Avricore Health Inc.

Avricore Health Refocuses Strategy to Unlock Growth Potential

a year ago - By: Avricore Health Inc.

Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch

a year ago - By: Avricore Health Inc.

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

2 years ago - By: Avricore Health Inc.

Avricore Health Corporate Update and Audited Results for 2023

2 years ago - By: Avricore Health Inc.

Avricore Grants Options

2 years ago - By: Avricore Health Inc.

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

2 years ago - By: Avricore Health Inc.

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

2 years ago - By: Avricore Health Inc.

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

2 years ago - By: Avricore Health Inc.

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

2 years ago - By: Avricore Health Inc.

Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members

3 years ago - By: Avricore Health Inc.

Avricore Health Corporate Updates on Audited Results for 2022

3 years ago - By: Avricore Health Inc.

Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection

3 years ago - By: Avricore Health Inc.

Avricore Health Makes the Grade on 2023 TSX Venture 50

3 years ago - By: Avricore Health Inc.

Avricore Health Reports Third-Quarter 2022 Results

3 years ago - By: Avricore Health Inc.

Avricore Health Announces CEO Update Call on Sept. 22, 2022

3 years ago - By: Avricore Health Inc.

Avricore Health Supports the Globe and Mail’s Health Innovation Event

3 years ago - By: Avricore Health Inc.

Avricore Health Reports Second-Quarter 2022 Results

3 years ago - By: Avricore Health Inc.

Avricore Grants Options

3 years ago - By: Avricore Health Inc.

Healthtab™ Expands With Shoppers Drug Mart®

3 years ago - By: Avricore Health Inc.

Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update

4 years ago - By: Avricore Health Inc.

Avricore Health CEO and Special Guests Join Radius Research for Investor Update

4 years ago - By: Avricore Health Inc.

Avricore Health CEO Hosts Investor Call December 15th

4 years ago - By: Avricore Health Inc.

HealthTab™ to Offer Abbott’s i-STAT Alinity™, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada

4 years ago - By: Avricore Health Inc.

HealthTab™ Expands to British Columbia in Select Shoppers Drug Mart® Locations

4 years ago - By: Avricore Health Inc. - Mentions: OTC

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Mission to Make Health Info Accessible to All

4 years ago - By: Avricore Health Inc. - Mentions: OTC

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry